Abstract Non-enzymatic glycosylation of proteins results in the formation of advanced glycation end products (AGEs). AGE modification of proteins and thereby damages to cells and tissues have been confirmed to contribute to the pathophysiology of aging and long-term complications of various age-related diseases. Anti-AGEs therapy has thus received significant attention, and several flavonoids including quercetin (1) and (-)-epigallocatechin gallate (EGCG) (2) have shown anti-AGEs activity through trapping and inactivating methylglyoxal (MGO), the crucial intermediate of AGEs formation. However, in the field of MGO-scavenging activity, (-)-epigallocatechin (EGC) (3), one of the key flavonoids in green tea, has received less attention compared with other flavonoids. In this study, we have shown strong MGO-scavenging activity of EGC (3), and EGC (3) was found to be equipotent to previously identified MGO-scavengers such as quercetin (1) and EGCG (2).
Introduction
Advanced glycation end products (AGEs) result from nonenzymatic glycosylation of macromolecules (proteins, phospholipids, and nucleic acids) upon exposure to glucose, fructose, and trioses. AGE modification of proteins results in protein dysfunction as well as damage in cells and tissues, and it has been confirmed that AGE-induced damage contributes to the pathophysiology of aging and long-term complications of diabetes [1] , neurological diseases [2] , atherosclerosis [3] , and renal failure [4] .
AGE formation is a complicated process, and many reactive intermediates are involved in this reaction. Among those, dicarbonyl intermediates such as glyoxal (GO), methylglyoxal (MGO), and 3-deoxyglucosone (3DG) have been reported as crucial precursors of AGEs because, due to the presence of reactive carbonyl groups, they can modify proteins to form AGEs of various chemical structures [5] . In particular, MGO has been given much attention because of its possible clinical significance in diabetes and its related complications [6] .
Trapping and inactivating MGO have thus been recognized as the most viable approach to anti-AGEs therapy, and many MGO-scavengers [7] have been reported. However, side effects associated with these compounds impeded further development as antiglycative agents [8] . Accordingly, safety has become one of the most important requirements for MGO-scavengers and thereby anti-AGEs agents.
Natural compounds from plant sources, which are characterized by proven safety profiles along with broadspectrum bioactivities, have thus become the subject of investigation for development of safe MGO-scavengers [9] [10] [11] . Flavonoids have also been tested for MGO-scavenging activity, and some of them including quercetin (1, Fig. 1 ) [12] and (-)-epigallocatechin-3-gallate (EGCG) (2, Fig. 1 ) [13] showed significant MGO-scavenging activity.
(-)-Epigallocatechin (EGC) (3, Fig. 1 ), another major flavonoid rich in green tea, also has various health-promoting effects [14, 15] , but in the field of MGO-scavenging activity, EGC (3) has received less attention compared with EGCG (2) . Therefore, in the course of our ongoing efforts to discover safe MGO-scavengers, it was of our interest to examine MGO-scavenging activity as well as anti-AGEs activity of EGC (3) in comparison with other flavonoids such as EGCG (2) and quercetin (1).
Materials and methods

Materials
Flavonoids were purchased from Xi'an Le Sen Bio-technology (EGC and EGCG) (Xi'an City, China) and SigmaAldrich (quercetin) (St. Louis, MO. USA). MGO (5 mM in 100 mM phosphate buffer) and 1,2-diaminobenzene (DB) were purchased from Sigma-Aldrich (St. Louis, MO. USA). BSA, dimethyl sulfoxide (DMSO), and phosphatebuffered saline (PBS) were obtained from RMBIO (Missoula, MT, USA), Merck Millipore (Burlington, MA, USA), and HyClone Laboratories (Logan, UT, USA), respectively. AGEs fluorescence (k ex 340 nm; k em 420 nm) was measured in a black plate 96 well (SPL Life Sciences, Gyeonggi-do, Korea) by using a CYTATION5 image reader (Biotek, Winooski, VT, USA). Results and discussion
MGO-scavenging assay
MGO-scavenging activity of EGC (3), EGCG (2), and quercetin (1) was determined by following previously published protocols [16] . The results summarized in Fig. 2 show that EGC (3) decreased MGO in a dose-dependent manner and, at 2.5 mM, no appreciable amount of MGO was detected after 10 min of incubation ( Fig. 2A) . EGCG (2) and quercetin (1) showed almost the same pattern in reducing MGO, and MGO levels dropped depending on the concentrations of the flavonoids as well as the time of incubation (Figs. 2B, 2C , respectively). In Fig. 3 , the kinetics of MGO-scavenging activity of EGC (3), EGCG (2), and quercetin (1) was compared at different concentrations (0.25, 0.5, 1.5, and 2.5 mM). In these plots, it is clearly shown that EGC (3) and EGCG (2) are equally potent in scavenging MGO, while quercetin (1) is less efficient than EGC (3) and EGCG (2) .
BSA (bovine serum albumin)-MGO assay
Mechanistically, the non-enzymatic glycation of proteins, Maillard reaction, is composed of three stages [2] , and the BSA-MGO assay is a specific method for investigation of inhibitors on middle stage of the glycation of protein. The BSA-MGO assay was performed by incubating BSA and MGO in the absence or presence of EGC, EGCG, or quercetin in phosphate buffer (pH 7.4). Under these assay conditions, a reaction between BSA and MGO produces AGEs, which are easily detectable through fluorescence spectroscopy (k ex = 340 nm, k em = 420 nm). The %-inhibition of AGEs formation by the flavonoids is summarized in Fig. 4 . As anticipated by the MGO-scavenging activity, the flavonoids [EGC (3), EGCG (2), and quercetin (1)] showed inhibitory activity against AGEs formation in a dose-dependent manner (Fig. 4) . In the presence of EGC (3), the inhibition efficiency was found to increase with increasing concentration of EGC (3) from 0.25 to 2.5 mM.
The maximum inhibition efficiency 77% was observed in the presence of 2.5 mM of EGC (3) in the BSA-MGO assay system (Fig. 4) . In summary, AGE modification of proteins and thereby damages to cells and tissues have been confirmed to contribute to the pathophysiology of aging and long-term complications of various age-related diseases. Anti-AGEs therapy has thus received significant attention, and several flavonoids have shown anti-AGEs activity through trapping and inactivating MGO, the crucial intermediate of AGEs formation. However, in the field of MGO-scavenging activity, EGC (3) has received less attention compared with other flavonoids. In this study, we have shown strong MGO-scavenging activity of EGC (3), and EGC (3) was equipotent to previously identified MGO-scavengers such as EGCG (2) and quercetin (1). 
